Literature DB >> 25412630

Regulation of c-Myc protein stability by proteasome activator REGγ.

S Li1, C Jiang2, J Pan3, X Wang3, J Jin3, L Zhao3, W Pan3, G Liao3, X Cai4, X Li3, J Xiao4, J Jiang5, P Wang6.   

Abstract

c-Myc is a key transcriptional factor that has a prominent role in cell growth, differentiation and tumor development. Its protein levels are tightly controlled by ubiquitin-proteasome pathway and frequently deregulated in various cancers. Here, we report that the 11S proteasomal activator REGγ is a novel regulator of c-Myc abundance in cells. We showed that overexpression of wild-type REGγ, but not inactive mutants including N151Y and G250S, significantly promoted the degradation of c-Myc. Depletion of REGγ markedly increased the protein stability of c-Myc. REGγ interacts with the C-terminal region of c-Myc and regulates c-Myc protein turnover. Functionally, REGγ negatively regulates c-Myc-mediated cell proliferation. Interestingly, depletion of the Drosophila Reg homolog (dReg) in developing wings induced the upregulation of Drosophila Myc, which contributes to cell death. Collectively, these results suggest that REGγ proteasome has a conserved role in the regulation of Myc abundance in both mammalian cells and Drosophila.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25412630      PMCID: PMC4423183          DOI: 10.1038/cdd.2014.188

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  47 in total

Review 1.  The 26S proteasome: a molecular machine designed for controlled proteolysis.

Authors:  D Voges; P Zwickl; W Baumeister
Journal:  Annu Rev Biochem       Date:  1999       Impact factor: 23.643

2.  Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7.

Authors:  Masayoshi Yada; Shigetsugu Hatakeyama; Takumi Kamura; Masaaki Nishiyama; Ryosuke Tsunematsu; Hiroyuki Imaki; Noriko Ishida; Fumihiko Okumura; Keiko Nakayama; Keiichi I Nakayama
Journal:  EMBO J       Date:  2004-04-22       Impact factor: 11.598

3.  Ubiquitylation of the amino terminus of Myc by SCF(β-TrCP) antagonizes SCF(Fbw7)-mediated turnover.

Authors:  Nikita Popov; Christina Schülein; Laura A Jaenicke; Martin Eilers
Journal:  Nat Cell Biol       Date:  2010-09-19       Impact factor: 28.824

Review 4.  Transcriptional regulation and transformation by Myc proteins.

Authors:  Sovana Adhikary; Martin Eilers
Journal:  Nat Rev Mol Cell Biol       Date:  2005-08       Impact factor: 94.444

5.  Proteasome activator PA28{gamma} stimulates degradation of GSK3-phosphorylated insulin transcription activator MAFA.

Authors:  Kenichi Kanai; Shinsaku Aramata; Sayo Katakami; Kunio Yasuda; Kohsuke Kataoka
Journal:  J Mol Endocrinol       Date:  2011-08-03       Impact factor: 5.098

Review 6.  MYC oncogenes and human neoplastic disease.

Authors:  C E Nesbit; J M Tersak; E V Prochownik
Journal:  Oncogene       Date:  1999-05-13       Impact factor: 9.867

Review 7.  The proteasome activator 11 S REG (PA28) and class I antigen presentation.

Authors:  M Rechsteiner; C Realini; V Ustrell
Journal:  Biochem J       Date:  2000-01-01       Impact factor: 3.857

8.  Inhibition of c-Myc activity by ribosomal protein L11.

Authors:  Mu-Shui Dai; Hugh Arnold; Xiao-Xin Sun; Rosalie Sears; Hua Lu
Journal:  EMBO J       Date:  2007-06-28       Impact factor: 11.598

9.  REG-γ associates with and modulates the abundance of nuclear activation-induced deaminase.

Authors:  Yasuhiro Uchimura; Lance F Barton; Cristina Rada; Michael S Neuberger
Journal:  J Exp Med       Date:  2011-10-31       Impact factor: 14.307

10.  Targeted gene expression as a means of altering cell fates and generating dominant phenotypes.

Authors:  A H Brand; N Perrimon
Journal:  Development       Date:  1993-06       Impact factor: 6.868

View more
  21 in total

1.  Interleukin-1β Activates a MYC-Dependent Metabolic Switch in Kidney Stromal Cells Necessary for Progressive Tubulointerstitial Fibrosis.

Authors:  Dario R Lemos; Michael McMurdo; Gamze Karaca; Julia Wilflingseder; Irina A Leaf; Navin Gupta; Tomoya Miyoshi; Koichiro Susa; Bryce G Johnson; Kirolous Soliman; Guanghai Wang; Ryuji Morizane; Joseph V Bonventre; Jeremy S Duffield
Journal:  J Am Soc Nephrol       Date:  2018-05-08       Impact factor: 10.121

2.  A circular RNA promotes tumorigenesis by inducing c-myc nuclear translocation.

Authors:  Qi Yang; William W Du; Nan Wu; Weining Yang; Faryal Mehwish Awan; Ling Fang; Jian Ma; Xiangmin Li; Yan Zeng; Zhenguo Yang; Jun Dong; Azam Khorshidi; Burton B Yang
Journal:  Cell Death Differ       Date:  2017-06-16       Impact factor: 15.828

3.  Small Molecule 20S Proteasome Enhancer Regulates MYC Protein Stability and Exhibits Antitumor Activity in Multiple Myeloma.

Authors:  Evert Njomen; Allison Vanecek; Theresa A Lansdell; Ya-Ting Yang; Peter Z Schall; Christi M Harris; Matthew P Bernard; Daniel Isaac; Omar Alkharabsheh; Anas Al-Janadi; Matthew B Giletto; Edmund Ellsworth; Catherine Taylor; Terence Tang; Sarah Lau; Marc Bailie; Jamie J Bernard; Vilma Yuzbasiyan-Gurkan; Jetze J Tepe
Journal:  Biomedicines       Date:  2022-04-19

4.  Knockdown of REGγ inhibits proliferation by inducing apoptosis and cell cycle arrest in prostate cancer.

Authors:  Shaojun Chen; Longsheng Wang; Chen Xu; Hui Chen; Bo Peng; Yunfei Xu; Xudong Yao; Lei Li; Junhua Zheng
Journal:  Am J Transl Res       Date:  2017-08-15       Impact factor: 4.060

Review 5.  MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies.

Authors:  Seyed Esmaeil Ahmadi; Samira Rahimi; Bahman Zarandi; Rouzbeh Chegeni; Majid Safa
Journal:  J Hematol Oncol       Date:  2021-08-09       Impact factor: 17.388

6.  The oncogenic role of REG γ is exerted by activating the Wnt/β-catenin signaling pathway in osteosarcoma.

Authors:  Zhiqiang Yin; Zhibin Peng; Zhichao Wang; Qinggang Meng
Journal:  Am J Transl Res       Date:  2020-02-15       Impact factor: 4.060

7.  Reciprocal REGγ-mTORC1 regulation promotes glycolytic metabolism in hepatocellular carcinoma.

Authors:  Liangfang Yao; Yang Xuan; Haiyang Zhang; Bo Yang; Xinglong Ma; Tianzhen Wang; Tianyuan Meng; Wenshe Sun; Haibin Wei; Xueqing Ma; Robb Moses; Jianru Xiao; Pei Zhang; Chao Ge; Jinjun Li; Lei Li; Xiaotao Li; Jinbao Li; Bianhong Zhang
Journal:  Oncogene       Date:  2020-11-23       Impact factor: 9.867

8.  BRD7 Promotes Cell Proliferation and Tumor Growth Through Stabilization of c-Myc in Colorectal Cancer.

Authors:  Ran Zhao; Yukun Liu; Chunchun Wu; Mengna Li; Yanmei Wei; Weihong Niu; Jing Yang; Songqing Fan; Yong Xie; Hui Li; Wei Wang; Zhaoyang Zeng; Wei Xiong; Xiaoling Li; Guiyuan Li; Ming Zhou
Journal:  Front Cell Dev Biol       Date:  2021-05-24

9.  OncoPPi-informed discovery of mitogen-activated protein kinase kinase 3 as a novel binding partner of c-Myc.

Authors:  A A Ivanov; V Gonzalez-Pecchi; L F Khuri; Q Niu; Y Wang; Y Xu; Y Bai; X Mo; E V Prochownik; M A Johns; Y Du; F R Khuri; H Fu
Journal:  Oncogene       Date:  2017-06-19       Impact factor: 9.867

Review 10.  Controlling the Master: Chromatin Dynamics at the MYC Promoter Integrate Developmental Signaling.

Authors:  Olga Zaytseva; Leonie M Quinn
Journal:  Genes (Basel)       Date:  2017-04-11       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.